Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Boccardo

Showing results (71-80 of 189) with videos related to

Pageof 19
Sort By:
The Prostate|January 1, 1994
Effect of the nonsteroidal antiandrogen nilutamide on adrenal androgen secretionA Decensi, R Torrisi, P Marroni, et al.
Lymphology|June 2, 2007
Functional magnetic resonance evidence of cortical alterations in a case of reversible congenital lymphedema of the lower limb: a pilot studyM Pardini, L Bonzano, L Roccatagliata, et al.
Oncology|January 1, 1990
Role of blood groups as prognostic factors in primary breast cancerM Costantini, T Fassio, L Canobbio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Paclitaxel plus organoplatins: still the gold standard in advanced ovarian cancer?F Boccardo, L Miglietta, M Bruzzone, et al.
Clinical and Experimental Rheumatology|July 9, 2003
Lusorian artery simulating rheumatic diseasesM G Alpigiani, O Burlando, S Compagnone, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Suramin/epidoxorubicin association in hormone-refractory prostate cancer: preliminary results of a pilot phase II studyL Miglietta, L Canobbio, C Granetto, et al.
Lymphology|June 16, 2018
Chyloperitoneum: Diagnostic and Therapeutic OptionsS Dessalvi, F Boccardo, L Molinari, et al.
BMC Cancer|February 14, 2016
The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcomeP V Nuzzo, A Rubagotti, L Zinoli, et al.
Lymphology|June 16, 2018
Congenital Chylothorax of the Newborn: Diagnosis and Treatment in Three PicturesC Bellini, R Cabano, T Bellini, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1990
Phase II study of tamoxifen and high-dose retinyl acetate in patients with advanced breast cancerF Boccardo, L Canobbio, M Resasco, et al.
Pageof 19

Showing results (71-80 of 189) with videos related to

Sort By:
Pageof 19
The Prostate|January 1, 1994
Effect of the nonsteroidal antiandrogen nilutamide on adrenal androgen secretionA Decensi, R Torrisi, P Marroni, et al.
Lymphology|June 2, 2007
Functional magnetic resonance evidence of cortical alterations in a case of reversible congenital lymphedema of the lower limb: a pilot studyM Pardini, L Bonzano, L Roccatagliata, et al.
Oncology|January 1, 1990
Role of blood groups as prognostic factors in primary breast cancerM Costantini, T Fassio, L Canobbio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Paclitaxel plus organoplatins: still the gold standard in advanced ovarian cancer?F Boccardo, L Miglietta, M Bruzzone, et al.
Clinical and Experimental Rheumatology|July 9, 2003
Lusorian artery simulating rheumatic diseasesM G Alpigiani, O Burlando, S Compagnone, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Suramin/epidoxorubicin association in hormone-refractory prostate cancer: preliminary results of a pilot phase II studyL Miglietta, L Canobbio, C Granetto, et al.
Lymphology|June 16, 2018
Chyloperitoneum: Diagnostic and Therapeutic OptionsS Dessalvi, F Boccardo, L Molinari, et al.
BMC Cancer|February 14, 2016
The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcomeP V Nuzzo, A Rubagotti, L Zinoli, et al.
Lymphology|June 16, 2018
Congenital Chylothorax of the Newborn: Diagnosis and Treatment in Three PicturesC Bellini, R Cabano, T Bellini, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1990
Phase II study of tamoxifen and high-dose retinyl acetate in patients with advanced breast cancerF Boccardo, L Canobbio, M Resasco, et al.
Pageof 19